Your browser doesn't support javascript.
loading
Metabolomics as read-across tool: An example with 3-aminopropanol and 2-aminoethanol.
Sperber, S; Wahl, M; Berger, F; Kamp, H; Lemke, O; Starck, V; Walk, T; Spitzer, M; Ravenzwaay, B V.
  • Sperber S; BASF SE, Ludwigshafen, Germany. Electronic address: Saskia.sperber@basf.com.
  • Wahl M; BASF SE, Ludwigshafen, Germany.
  • Berger F; BASF SE, Ludwigshafen, Germany.
  • Kamp H; BASF SE, Ludwigshafen, Germany.
  • Lemke O; BASF SE, Ludwigshafen, Germany.
  • Starck V; BASF SE, Ludwigshafen, Germany.
  • Walk T; BASF Metabolome Solutions GmbH, Berlin, Germany.
  • Spitzer M; BASF Metabolome Solutions GmbH, Berlin, Germany.
  • Ravenzwaay BV; BASF SE, Ludwigshafen, Germany.
Regul Toxicol Pharmacol ; 108: 104442, 2019 Nov.
Article en En | MEDLINE | ID: mdl-31421187
ABSTRACT
Read-across and grouping is one of the most commonly used alternative approaches for data gap filling in registrations submitted under the REACH Regulation as defined by the European Chemicals Agency (ECHA) in their 'Read-Across Assessment Framework' (RAAF, 2017). At the same time, the application of read-across is rejected by ECHA frequently due to various reasons. As a major reason hereof, applicants fail to reduce the level of 'remaining uncertainty' intrinsical to every read-across approach compared to testing a substance experimentally. Recently, the use of metabolomics to support read-across cases with biological information has been reported in a case study with phenoxy herbicides (Ravenzwaay et al., 2016). In the present case-study a 'weight-of-evidence' read-across approach from 2-aminoethanol (MEA = 'source') to 3-aminopropanol (3AP = 'target') with metabolomics as 'supporting evidence' reducing the remaining uncertainties is reported. We demonstrate the high structural similarity of the two analogous substances based on the available data and we report how metabolome data add confidence concerning mechanistic similarity in this read-across approach. Finally, the herein described read-across case supported by metabolomics is used to cover the data gaps in repeated dose and reproductive toxicity endpoint of 3AP via weight of evidence for the REACH-registration.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Propanolaminas / Etanolamina / Metaboloma Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Propanolaminas / Etanolamina / Metaboloma Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Animals Idioma: En Año: 2019 Tipo del documento: Article